Evidence map›Paper›PMID 34860176›Full record

ArticleEndocrine connections2022

Reduced pituitary size in subjects with mutations in the THRB gene and thyroid hormone resistance.

Marcus Heldmann, Krishna Chatterjee, Carla Moran, Berenike Rogge, Julia Steinhardt, Tobias Wagner-Altendorf, Martin Göttlich, Hannes Schacht, Peter Schramm, Georg Brabant and 2 more

Open access · goldAbstract read
In one paragraph

Article in Endocrine connections, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Marcus HeldmannDepartment of Neurology, University of Lübeck, Lübeck, Germany.
Krishna ChatterjeeWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Carla MoranWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Berenike RoggeDepartment of Neurology, University of Lübeck, Lübeck, Germany.
Julia SteinhardtDepartment of Neurology, University of Lübeck, Lübeck, Germany.
Tobias Wagner-AltendorfDepartment of Neurology, University of Lübeck, Lübeck, Germany.
Martin GöttlichDepartment of Neurology, University of Lübeck, Lübeck, Germany.
Hannes SchachtDepartment of Neuroradiology, University of Lübeck, Lübeck, Germany.
Peter SchrammDepartment of Neuroradiology, University of Lübeck, Lübeck, Germany.
Georg BrabantDepartment of Internal Medicine I, University of Lübeck, Lübeck, Germany.
Thomas F MünteDepartment of Neurology, University of Lübeck, Lübeck, Germany.
Anna CirkelDepartment of Neurology, University of Lübeck, Lübeck, Germany.ORCID 0000-0001-8637-9637
University of Lübeck · DEUniversity of Cambridge · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thyroid hormone action is mediated by two forms of thyroid hormone receptors (α, β) with differential tissue distribution. Thyroid hormone receptor β (TRβ) mutations lead to resistance to thyroid hormone action in tissues predominantly expressing the β form of the receptor (pituitary, liver). This study seeks to identify the effects of mutant TRβ on pituitary size. Methods: High-resolution 3D T1-weighted magnetic resonance images were acquired in 19 patients with RTHβ in comparison to 19 healthy matched controls. Volumetric measurements of the pituitary gland were performed independently and blinded by four different raters (two neuroradiologists, one neurologist, one neuroscientist). Results: Patients with mutant TRβ (resistance to thyroid hormone β, RTHβ) showed elevated free tri-iodothyronine/thyroxine levels with normal thyroid-stimulating hormone levels, whereas healthy controls showed normal thyroid hormone levels. Imaging revealed smaller pituitary size in RTHβ patients in comparison to healthy controls (F(1,35) = 7.05, P = 0.012, partial η2 = 0.17). Conclusion: RTHβ subjects have impaired sensitivity to thyroid hormones, along with decreased size of the pituitary gland.

Indexed as

pituitarythyroidthyroid hormone receptorthyroid hormone resistance

Identifiers

PMID34860176
PMCPMC8789019
OpenAlexW3216504615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.